Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1277 | 2643 | 22.5 | 49% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
434 | 15650 | CHEMOTHERAPY-TOKYO//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//CEFEPIME |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CHEMOTHERAPY-TOKYO | Journal | 59 | 48% | 3% | 90 |
2 | JAPANESE JOURNAL OF ANTIBIOTICS | Journal | 43 | 62% | 2% | 44 |
3 | RANCHI VET SCI ANIM HUSB | Address | 2 | 67% | 0% | 2 |
4 | DOSAGE REGIMEN | Author keyword | 2 | 14% | 0% | 12 |
5 | CEFTIZOXIME | Author keyword | 2 | 23% | 0% | 7 |
6 | CAS 61622 34 2 | Author keyword | 1 | 100% | 0% | 2 |
7 | TISSUE CAGE FLUID | Author keyword | 1 | 50% | 0% | 2 |
8 | CEFTRIAXON | Author keyword | 1 | 40% | 0% | 2 |
9 | DESACETYLCEFOTAXIME | Author keyword | 1 | 27% | 0% | 3 |
10 | CANINE FEMALES | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DOSAGE REGIMEN | 2 | 14% | 0% | 12 | Search DOSAGE+REGIMEN | Search DOSAGE+REGIMEN |
2 | CEFTIZOXIME | 2 | 23% | 0% | 7 | Search CEFTIZOXIME | Search CEFTIZOXIME |
3 | CAS 61622 34 2 | 1 | 100% | 0% | 2 | Search CAS+61622+34+2 | Search CAS+61622+34+2 |
4 | TISSUE CAGE FLUID | 1 | 50% | 0% | 2 | Search TISSUE+CAGE+FLUID | Search TISSUE+CAGE+FLUID |
5 | CEFTRIAXON | 1 | 40% | 0% | 2 | Search CEFTRIAXON | Search CEFTRIAXON |
6 | DESACETYLCEFOTAXIME | 1 | 27% | 0% | 3 | Search DESACETYLCEFOTAXIME | Search DESACETYLCEFOTAXIME |
7 | CANINE FEMALES | 1 | 50% | 0% | 1 | Search CANINE+FEMALES | Search CANINE+FEMALES |
8 | KINETIC VARIABLES | 1 | 50% | 0% | 1 | Search KINETIC+VARIABLES | Search KINETIC+VARIABLES |
9 | MENINGITIS BACTERIAL DRUG THERAPY | 1 | 50% | 0% | 1 | Search MENINGITIS++BACTERIAL+DRUG+THERAPY | Search MENINGITIS++BACTERIAL+DRUG+THERAPY |
10 | PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS | 1 | 50% | 0% | 1 | Search PHARMACOKINETIC+AND+PHARMACODYNAMIC+PARAMETERS | Search PHARMACOKINETIC+AND+PHARMACODYNAMIC+PARAMETERS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DESACETYLCEFOTAXIME | 15 | 51% | 1% | 21 |
2 | DESACETYL CEFOTAXIME | 11 | 78% | 0% | 7 |
3 | SERIOUS CHEST INFECTIONS | 6 | 80% | 0% | 4 |
4 | DESACETYLCEFOTAXIME PHARMACOKINETICS | 4 | 75% | 0% | 3 |
5 | CROSS BRED CALVES | 3 | 100% | 0% | 3 |
6 | GYNECOLOGICAL TISSUES | 3 | 100% | 0% | 3 |
7 | DOSAGE REGIMEN | 2 | 14% | 0% | 13 |
8 | CEFUROXIME PLUS GENTAMICIN | 1 | 100% | 0% | 2 |
9 | DISTRIBUTION TERMS | 1 | 50% | 0% | 2 |
10 | EXPERIMENTAL ESCHERICHIA COLI | 1 | 50% | 0% | 2 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHEMOTHERAPY-TOKYO | 59 | 48% | 3% | 90 |
2 | JAPANESE JOURNAL OF ANTIBIOTICS | 43 | 62% | 2% | 44 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Pharmacokinetics of cephalosporins in the neonate: a review | 2011 | 7 | 38 | 74% |
PENETRATION OF NEWER CEPHALOSPORINS INTO CEREBROSPINAL-FLUID | 1989 | 56 | 110 | 91% |
Clinical use of ceftriaxone - A pharmacokinetic-pharmacodynamic perspective on the impact of minimum inhibitory concentration and serum protein binding | 2001 | 27 | 27 | 63% |
CLINICAL PHARMACOKINETICS OF THE 3RD GENERATION CEPHALOSPORINS | 1985 | 94 | 227 | 80% |
Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis | 2007 | 9 | 47 | 62% |
CEFTRIAXONE - A REAPPRAISAL OF ITS ANTIBACTERIAL ACTIVITY AND PHARMACOKINETIC PROPERTIES, AND AN UPDATE ON ITS THERAPEUTIC USE WITH PARTICULAR REFERENCE TO ONCE-DAILY ADMINISTRATION | 1988 | 59 | 159 | 63% |
DRUG-THERAPY - BETA-LACTAM ANTIBIOTICS .2. | 1988 | 92 | 190 | 42% |
ANTIBIOTIC-THERAPY FOR ENTEROBACTER MENINGITIS - A RETROSPECTIVE REVIEW OF 13 EPISODES AND REVIEW OF THE LITERATURE | 1993 | 21 | 20 | 60% |
THE NEW BETA-LACTAMASE-STABLE CEPHALOSPORINS | 1982 | 279 | 44 | 84% |
CEFTRIAXONE - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE | 1984 | 123 | 152 | 71% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RANCHI VET SCI ANIM HUSB | 2 | 67% | 0.1% | 2 |
2 | CENT SURG SERV | 1 | 50% | 0.0% | 1 |
3 | INORGAN CHEM BIOINORGAN | 1 | 50% | 0.0% | 1 |
4 | LOCAL HLTH UNIT 3 | 1 | 50% | 0.0% | 1 |
5 | MYERS BLACK INFECT DIS SECT | 1 | 50% | 0.0% | 1 |
6 | PEDIAT CHILDRENS NUTR USDA ARS | 1 | 50% | 0.0% | 1 |
7 | SCI COMMISS PROV BUENOS AI | 1 | 50% | 0.0% | 1 |
8 | 800 MARSHALL ST | 0 | 33% | 0.0% | 1 |
9 | AOC CAREGGI | 0 | 33% | 0.0% | 1 |
10 | EXPT INFECTINFECT DIS SERV | 0 | 33% | 0.0% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000170817 | RUMINANT DIS EPIDEMIOL//SUCTION BLISTER METHOD//SKIN BLISTER FLUID CONCENTRATION |
2 | 0.0000165917 | AZLOCILLIN//MEZLOCILLIN//ANIMAL MODELS ALTERNATIVES |
3 | 0.0000160981 | PSEUDOLITHIASIS//BILIARY PSEUDOLITHIASIS//INSOLUBLE MICROPARTICLE |
4 | 0.0000153529 | DISULFIRAM LIKE REACTION//HYPOPROTHROMBINEMIA//HYPOPROTHROMBINAEMIA |
5 | 0.0000120775 | CEFEPIME//CEFPIROME//FK037 |
6 | 0.0000116471 | NAGZ//AMPG//AMPR |
7 | 0.0000108098 | MC 1//AZTREONAM//MONOBACTAM |
8 | 0.0000105408 | TEMOCILLIN//AFDELING MED MICROBIOL INFECTIEZIEKTEN//P OFF |
9 | 0.0000101531 | MED BIOL PHARM//URINE BACTERICIDAL ACTIVITY// |
10 | 0.0000093930 | CEFROXADINE//ABSCESS PENETRATION//RADICULAR GRANULOMA |